Posttransplant bacteremia in adult living donor liver transplant recipients

Liver Transplantation

Volumn 16, Issue 12, 2010, Pages 1379-1385

  Iida, Taku ^a   Kaido, Toshimi ^a   Yagi, Shintaro ^a   Yoshizawa, Atsushi ^a   Hata, Koichiro ^a   Mizumoto, Masaki ^a   Mori, Akira ^a   Ogura, Yasuhiro ^a   Oike, Fumitaka ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; RITUXIMAB; STEROID; TACROLIMUS;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL LIVER CIRRHOSIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BACTEREMIA; BACTERIUM ISOLATION; BILE DUCT ATRESIA; BLOOD GROUP ABO INCOMPATIBILITY; CONTINUOUS INFUSION; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION CONTROL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK ASSESSMENT; STEROID THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; ENTEROCOCCUS; FEMALE; HUMANS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 78649890618     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22165     Document Type: Article

References (20)

1. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S., In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl 2009; 15: 1420-1425.
2. Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, Fantin B,. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008; 21: 755-763.
3. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera M, Gayowski T., Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004; 10: 844-849.
4. Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M,. Bloodstream infection after living donor liver transplantation. Scand J Infect Dis 2008; 40: 509-516. (Pubitemid 351997669)
5. Kim YJ, Kim SI, Wie SH, Kim YR, Hur JA, Choi JY, et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis 2008; 10: 316-324.
6. Kim SI, Kim YJ, Jun YH, Wie SH, Kim YR, Choi JY, et al. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J 2009; 50: 112-121.
7. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247-252. (Pubitemid 26044539)
8. Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, et al. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Transplantation 2006; 81: 350-354.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM., CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
10. Saner FH, Olde Damink SW, Pavlakovic G, van den Broek MA, Rath PM, Sotiropoulos GC, et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008; 85: 1564-1568.
11. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR., Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000; 6: 54-61.
12. Linares L, García-Goez JF, Cervera C, Almela M, Sanclemente G, Cofán F, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41: 2262-2264.
13. Kawecki D, Chmura A, Pacholczyk M, Śagiewska B, Adadynski L, Wasiak D, et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc 2007; 39: 2816-2821.
14. Gao LH, Zheng SS., Cytomegalovirus and chronic allograft rejection in liver transplantation. World J Gastroenterol 2004; 10: 1857-1861.
15. Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Kasahara M, et al. Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2009; 54: 2253-2263.
16. Martin M, Kusne S, Alessiani M, Simmons R, Starzl TE., Infections after liver transplantation: risk factors and prevention. Transplant Proc 1991; 23: 1929-1930.
17. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH,. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. HEPATOLOGY 1986; 6: 922-927.
18. Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS., Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 1988; 167: 474-484.
19. Colonna JO 2nd, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, et al. Infectious complications in liver transplantation. Arch Surg 1988; 123: 360-364.
20. Cueto G, Trigo P, Arata A, Rodríguez D, Braña E, Braslavsky G, et al. Evaluation of prognostic factors for early infection in liver transplantation. Transplant Proc 1999; 31: 3061-3062.